Mr. von Autenried, 61, served as the Chief Information Officer and an Executive Committee member of Bristol Myers Squibb Company, a publicly-traded biopharmaceutical company from 2011 through 2022, and prior to that role, he held various leadership positions since 1996. Prior to joining Bristol Myers Squibb, from 1991 through 1996, he served as Director of Technology at Kraft General Foods. Mr. von Autenried received a Bachelor of Electrical Engineering degree and a Master of Science in Computer Science degree from Stevens Institute of Technology in 1983 and 1986 respectively. Mr. von Autenried is a board member of QuickBase, and a board advisor for several other privately held technology companies, including Intelepeer, SafeGuard Cyber, and Dotmatics. Mr. von Autenried has also served on the board of several non-profit entities, and is currently on the board of PennMedicine Princeton Healthcare.
CEO & Director
David Coman joined Science 37 in November 2019 as Chief Executive Officer. He came to Science 37 from ERT, where he served as Chief Strategy Officer. As the leader of ERT’s data and analytics business, David reimagined the way the pharmaceutical industry looks at performance and risk management for clinical trials. Prior to ERT, David was Chief Marketing Officer of IQVIA, formerly Quintiles, where he was also the founder of its Digital Patient business and pioneered some of the industry’s first decentralized clinical trials. Prior to Quintiles, David was the Chief Marketing Officer at Dendrite International, which is also now owned by IQVIA. Earlier in his career, David held a variety of marketing leadership roles in telecommunications, including AOL Local & Long Distance (Talk America), Excel Communications, and Aerial Communications. David earned a B.A. in advertising from Michigan State University and an MBA in marketing, entrepreneurship, and finance from the Kellogg Graduate School of Management at Northwestern University.